Vaxart to Speak at World Vaccine Congress Washington 2024 on April 3

Revolutionizing Vaccine Delivery: Dr. Sean Tucker to Present at World Vaccine Congress Washington 2024

Vaxart, Inc., a South San Francisco, California-based clinical-stage biotechnology company, is thrilled to announce that its Founder and Chief Scientific Officer, Dr. Sean Tucker, will be presenting at the World Vaccine Congress Washington 2024 in Washington, D.C. on April 3, 2024.

During his presentation titled “Moving the needle: Blocking transmission and boosting existing vaccines by oral tablet vaccination,” Dr. Tucker will discuss how Vaxart’s proprietary delivery platform can revolutionize vaccine administration by allowing for easy storage and shipping without refrigeration while also eliminating the risk of needle-stick injuries.

Vaxart’s pill vaccine delivery platform is well-suited for delivering a range of vaccines, including oral versions of existing vaccines and new indications. The company’s development programs include pill vaccines for protection against coronavirus, norovirus, and influenza as well as a therapeutic vaccine for human papillomavirus (HPV), its first immune-oncology indication. In addition to these programs, Vaxart has filed various patent applications domestically and internationally to cover its proprietary technology and creations related to oral vaccination using adenovirus and TLR3 agonists.

For media relations inquiries please contact Mark Herr at Vaxart, Inc., while investors should reach out to Andrew Blazier for investor relations inquiries.

Leave a Reply

Bridging Work and Leisure with the Lenovo Tab P12 Previous post Experience Unmatched Versatility with Lenovo Tab P12: A Seamless Device for Remote Work and On-the-Go Fun
Join us at the SID/DSCC Business Conference 2024 to Connect with Counterpoint Research Next post Bob O’Brien: Navigating the Display and Electronics Industries with Expertise in Market Analysis and Business Strategy